🇺🇸 tbo-filgrastim in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised tbo-filgrastim on 29 August 2012

Marketing authorisation

FDA — authorised 29 August 2012

Application: BLA125294
Marketing authorisation holder: SICOR BIOTECH
Local brand name: GRANIX
Indication: INJECTABLE — INJECTION
Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is tbo-filgrastim approved in United States?

Yes. FDA authorised it on 29 August 2012.

Who is the marketing authorisation holder for tbo-filgrastim in United States?

SICOR BIOTECH holds the US marketing authorisation.